ID

28293

Beschreibung

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Third party follow-up - Repeating form (Scheduled/Dynamic visit)

Stichworte

Versionen (3)
  1. 12.10.17 12.10.17 -
  2. 23.10.17 23.10.17 -
  3. 02.01.18 02.01.18 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

2. Januar 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

Englisch

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulare  
Date of last contact attempt
Beschreibung

Date of last contact attempt

1. Date of most recent attempt to contact third party
Beschreibung

Date of last contact attempt

Datentyp

date

Alias
UMLS CUI [1]
C0805839
Contact details
Beschreibung

Contact details

2. Was contact successful? (i.e. actually spoke to someone)
Beschreibung

contact successful

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332158
UMLS CUI [1,2]
C0681850
If contact successful: Type of third party contact
Beschreibung

Type of third party contact

Datentyp

text

Alias
UMLS CUI [1,1]
C0332158
UMLS CUI [1,2]
C0332307
Other type of third party contact
Beschreibung

Other type of third party contact

Datentyp

text

Alias
UMLS CUI [1,1]
C0332158
UMLS CUI [1,2]
C0332307
Are there any new study endpoints to report?
Beschreibung

If Yes, complete SAE-EP and appropriate Endpoint forms.

Datentyp

text

Alias
UMLS CUI [1]
C2347784
Date endpoint information assessed by third party
Beschreibung

Date endpoint information assessed by third party

Datentyp

date

Alias
UMLS CUI [1,1]
C0025084
UMLS CUI [1,2]
C1303082
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Date of last contact attempt
Date of last contact attempt
Item
1. Date of most recent attempt to contact third party
date
C0805839 (UMLS CUI [1])
Item Group
Contact details
contact successful
Item
2. Was contact successful? (i.e. actually spoke to someone)
boolean
C0332158 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
Item
If contact successful: Type of third party contact
text
C0332158 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
Type of third party contact
Code List
If contact successful: Type of third party contact
CL Item
Investigative site staff (4)
C4036024 (UMLS CUI-1)
(Comment:en)
CL Item
Health care provider other than investigative site staff (1)
C0018724 (UMLS CUI-1)
(Comment:en)
CL Item
Family member (2)
C0086282 (UMLS CUI-1)
(Comment:en)
CL Item
Friend or neighbor (5)
C3842310 (UMLS CUI-1)
(Comment:en)
CL Item
Other (OT)
C0205394 (UMLS CUI-1)
(Comment:en)
Other type of third party contact
Item
Other type of third party contact
text
C0332158 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
Item
Are there any new study endpoints to report?
text
C2347784 (UMLS CUI [1])
new study endpoints
Code List
Are there any new study endpoints to report?
CL Item
Unknown (Third party not able to find out if subject did or did not have new study endpoint, or the only information available is vital status "death" without details) (U)
CL Item
No (Third party able to confirm no new study endpoints) (N)
CL Item
Yes (Third party able to confirm the presence of new study endpoints. Do not select this option if the only information available is vital status "death" without details) (Y)
Date endpoint information assessed by third party
Item
Date endpoint information assessed by third party
date
C0025084 (UMLS CUI [1,1])
C1303082 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video